Docetaxel
- Product NDC
- 0409-0366
- 11-digit product format
- 004090366
- Labeler code
- 0409
- Product ID
- 0409-0366_297f1202-b539-41ee-bf52-4b9b04dd3a60
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DOCETAXEL
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Hospira, Inc.
- Application
- NDA022234
- Marketing category
- NDA
- Marketing start
- 2016-08-24
- Substance
- DOCETAXEL
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022234-001 | DOCETAXEL | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 |
| N022234-002 | DOCETAXEL | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 |
| N022234-003 | DOCETAXEL | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 |
| N022234-004 | DOCETAXEL | DOCETAXEL | 20MG/ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | |
| N022234-005 | DOCETAXEL | DOCETAXEL | 80MG/4ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | |
| N022234-006 | DOCETAXEL | DOCETAXEL | 120MG/6ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | |
| N022234-007 | DOCETAXEL | DOCETAXEL | 160MG/8ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2017-01-24 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N022234-001 | AP |
| N022234-002 | AP |
| N022234-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022234-001 | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022234-002 | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022234-003 | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022234-004 | DOCETAXEL | 20MG/ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022234-005 | DOCETAXEL | 80MG/4ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022234-006 | DOCETAXEL | 120MG/6ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022234-007 | DOCETAXEL | 160MG/8ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2017-01-24 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022234-001 | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022234-002 | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022234-003 | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022234-004 | DOCETAXEL | 20MG/ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022234-005 | DOCETAXEL | 80MG/4ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022234-006 | DOCETAXEL | 120MG/6ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022234-007 | DOCETAXEL | 160MG/8ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2017-01-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022234-001 | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022234-002 | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022234-003 | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022234-004 | DOCETAXEL | 20MG/ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022234-005 | DOCETAXEL | 80MG/4ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022234-006 | DOCETAXEL | 120MG/6ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022234-007 | DOCETAXEL | 160MG/8ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2017-01-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022234-001 | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022234-002 | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022234-003 | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022234-004 | DOCETAXEL | 20MG/ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022234-005 | DOCETAXEL | 80MG/4ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022234-006 | DOCETAXEL | 120MG/6ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022234-007 | DOCETAXEL | 160MG/8ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2017-01-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022234-001 | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022234-002 | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022234-003 | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022234-004 | DOCETAXEL | 20MG/ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022234-005 | DOCETAXEL | 80MG/4ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022234-006 | DOCETAXEL | 120MG/6ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022234-007 | DOCETAXEL | 160MG/8ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2017-01-24 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022234-001 | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022234-002 | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022234-003 | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE / INJECTION | AP | RLD, RS | 2011-03-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022234-004 | DOCETAXEL | 20MG/ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022234-005 | DOCETAXEL | 80MG/4ML (20MG/ML) | INJECTABLE / INJECTION | RLD | 2016-06-23 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022234-002 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022234-003 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022234-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022234-002 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022234-003 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N022234-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N022234-002 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N022234-003 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022234-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022234-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022234-003 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N022234-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N022234-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N022234-003 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N022234-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N022234-002 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N022234-003 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N022234-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022234-002 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022234-003 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N022234-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N022234-002 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N022234-003 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N022234-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N022234-002 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N022234-003 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022234-001 | AP | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022234-002 | AP | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022234-003 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N022234-001 | AP | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N022234-002 | AP | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N022234-003 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N022234-001 | AP | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N022234-002 | AP | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N022234-003 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N022234-001 | AP | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N022234-002 | AP | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N022234-003 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N022234-001 | AP | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022234-002 | AP | 1 | 3f01610625f2… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Docetaxel
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOCETAXEL | 20 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 15H5577CQD | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3104aab1-cd6e-4ad2-8e0a-286a0c5d1940 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| be52172d-e80b-4aac-aa81-254100bce67f | Product name | 9 | 20260304 |
| c4fcacbc-a699-410c-905b-642c4d134e72 | Product name | 1 | 20250616 |
| ad3381c5-7539-4a18-83b7-e7382b118d04 | Product name | 1 | 20231117 |
| 60a22813-7270-4733-af61-30636bce9f0f | Product name | 4 | 20180820 |
| 0179c4ba-fb03-4931-875d-b4f1ba528029 | Product name | 1 | 20160107 |
| 9ff92ef8-2da9-4645-bbf8-642e7eb0d754 | Product name | 1 | 20150812 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-0366-01 | Docetaxel | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 1 | 24 | |
| 0409-0366-01 | Docetaxel | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 24 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-0366-01 | ML - Milliliter | 0409-0366 | 2dfb14c0-1f30-422d-a843-73efa502cbc2 | 1 | 2016-09-02 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Docetaxel | DOCETAXEL | Hospira, Inc. | 6b9999bb-869e-4d25-838c-23c3ab280044 | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | 022234 NDA022234 |
| Docetaxel | DOCETAXEL ANHYDROUS | Hospira, Inc. | 644c5035-20d2-4686-beaa-bef08e99051c | 2025-01-20 | Boxed warning, Warnings, Adverse reactions | 022234 NDA022234 |
| Docetaxel | DOCETAXEL ANHYDROUS | Hospira, Inc. | 00c61d11-d6b7-4618-b6f6-2592dbcc8af7 | 2025-01-20 | Boxed warning, Warnings, Adverse reactions | 022234 NDA022234 |
| Docetaxel | DOCETAXEL | Hospira, Inc. | 3104aab1-cd6e-4ad2-8e0a-286a0c5d1940 | 2024-09-19 | Boxed warning, Warnings, Adverse reactions | 022234 NDA022234 0409-0366 |
| Docetaxel | DOCETAXEL ANHYDROUS | Hospira, Inc. | a0ec4bcc-93ea-4c41-a4b6-95ec19491807 | 2024-08-22 | Boxed warning, Warnings, Adverse reactions | 022234 NDA022234 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1860480 | DOCEtaxel 20 MG in 1 ML Injection | PSN | 3104aab1-cd6e-4ad2-8e0a-286a0c5d1940 | 24 |
| 1001405 | DOCEtaxel 20 MG/ML Injectable Solution | PSN | 3104aab1-cd6e-4ad2-8e0a-286a0c5d1940 | 24 |
| 1860480 | 1 ML docetaxel 20 MG/ML Injection | SCD | 3104aab1-cd6e-4ad2-8e0a-286a0c5d1940 | 24 |
| 1001405 | docetaxel 20 MG/ML Injectable Solution | SCD | 3104aab1-cd6e-4ad2-8e0a-286a0c5d1940 | 24 |
| 1860480 | docetaxel 20 MG per 1 ML Injection | SY | 3104aab1-cd6e-4ad2-8e0a-286a0c5d1940 | 24 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0409-0366-01 | 00409036601 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0366-01) / 1 mL in 1 VIAL, SINGLE-DOSE | 2016-08-24 | 0000-00-00 | No | No | Current |